7Baggers

Biodesix Quarterly Income Statements Chart

Quarterly
 | 
Annual
 
 Revenue  
 Gross Profit  
 Operating Profit  
 Net Income  
20190631 20190930 20190931 20191231 20200331 20200630 20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 -16.35-9.89-3.433.039.4915.9522.4128.87Milllion

Biodesix Quarterly Income Statements Table

Quarterly
 | 
Annual
 
Unit: USD2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-31 2019-09-30 2019-06-31 2019-06-30 2019-03-31 2019-01-31 2018-09-31 2018-06-31 2018-06-30 2018-03-31 2018-01-31 
  revenue14,668,000 13,491,000 11,872,000 9,056,000 9,608,000 11,107,000 10,950,000 6,548,000 7,224,000 6,531,000 11,885,000 28,866,000 27,028,000 9,193,000 4,239,000 5,096,000 8,271,000 6,138,000 3,942,000 6,138,000 6,138,000 6,138,000 6,138,000 5,108,000 5,108,000 5,108,000 5,108,000 5,108,000 
  cost of revenue3,374,000 3,229,000 3,238,000 3,169,000 3,306,000 3,633,000 3,980,000 3,235,000 2,493,000 2,722,000 7,085,000 18,218,000 14,652,000 3,891,000 1,874,000 1,581,000 1,830,000 1,518,500 1,503,000 1,518,500 1,518,500 1,518,500 1,518,500 1,101,500 1,101,500 1,101,500 1,101,500 1,101,500 
  gross profit11,294,000 10,262,000 8,634,000 5,887,000 6,302,000 7,474,000 6,970,000 3,313,000 4,731,000 3,809,000 4,800,000 10,648,000 12,376,000 5,302,000 2,365,000 3,515,000 6,441,000 4,619,500 2,439,000 4,619,500 4,619,500 4,619,500 4,619,500 4,006,500 4,006,500 4,006,500 4,006,500 4,006,500 
  operating expenses                            
  research and development1,889,000 1,938,000 2,910,000 3,251,000 3,565,000 2,970,000 3,361,000 3,206,000 2,852,000 3,293,000 3,323,000 3,321,000 3,105,000 2,706,000 2,107,000 2,900,000 2,502,000 2,617,000 2,359,000 2,617,000 2,617,000 2,617,000 2,617,000 2,047,000 2,047,000 2,047,000 2,047,000 2,047,000 
  sales and marketing18,989,000 16,626,000 15,114,000 15,235,000 14,487,000 13,558,000 13,607,000 11,425,000 11,927,000 12,064,000 7,879,000 6,834,000 8,080,000 6,557,000 7,659,250 8,212,000 7,659,250 7,659,250 7,659,250 7,659,250 6,474,750 6,474,750 6,474,750 6,474,750 6,474,750 
  general and administrative                            
  total operating expenses26,978,000 7,879,000 7,659,250 7,659,250 6,474,750 6,474,750 
  operating income18,140,000 17,434,000 19,561,000 22,240,000 20,191,000 18,084,000 18,596,000 17,693,000 16,410,000 16,900,000 14,748,000 15,248,000 15,169,000 10,585,000 8,941,000 10,980,000 9,059,000 10,571,000 10,276,250 10,276,250 10,276,250 8,521,750 8,521,750 8,521,750 
  net income-6,846,000 -7,172,000 -10,927,000 -16,353,000 -13,889,000 -10,610,000 -11,626,000 -14,380,000 -11,679,000 -13,091,000 -10,587,000 -5,583,000 -2,655,000 -6,240,000 -5,619,000 -8,422,000 -3,544,000 -5,656,750 -9,028,000 -5,656,750 -5,656,750 -5,656,750 -5,656,750 -4,515,250 -4,515,250 -4,515,250 -4,515,250 -4,515,250 

We provide you with 20 years income statements for Biodesix stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Biodesix stock. Explore the full financial landscape of Biodesix stock with our expertly curated income statements.

The information provided in this report about Biodesix stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.